Stuart Alexander Scott

The paper identifies individuals with minor spliceopathies by analyzing transcriptome-wide splicing outliers in RNA-seq data from rare disease cohorts.

This study evaluates a pharmacogenomic-driven algorithm to guide antiplatelet therapy in Caribbean Hispanic patients post-PCI, showing reduced MACCE incidence with genotype-guided treatment.

Aldy 4 is a pharmacogenomics genotyper and star-allele caller that improves accuracy across sequencing technologies through combinatorial optimization and novel models.

The paper assesses if genetic risk for atrial fibrillation explains cardioembolic stroke risk using genome-wide data from the Stroke Genetics Network.